glp-1 podcast Your Bestie S4.E8: My Life on GLP-1:

Researchers concluded that those taking tirzepatide were significantly more likely to achieve weight loss, but added that more studies are needed to better understand the full range of benefits and effects both drugs have on patients

By the start of next year, drug manufacturer Novo Nordisk has pledged to slash the price of popular GLP-1 drugs like Ozempic and Wegovy by about 50%

Tennessee permits telehealth prescribing for weight loss medications

FDA Regulatory Notice: As of February 2026, the FDA has resolved the semaglutide drug shortage and has stated its intent to prioritize enforcement against certain mass-marketed non-FDA-approved GLP-1 products

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist, meaning it mimics the role of the naturally produced GLP-1 hormone that regulates feelings of fullness after eating